Andrew C. Jackson
CFO & Corporate SecretaryMr. Andrew C. Jackson serves as Chief Financial Officer at Calidi Biotherapeutics, Inc. since October 30, 2023 and serves as its Corporate Secretary since October 17, 2025. He served as Chief Financial Officer at Eterna Therapeutics Inc. (formerly known as Brooklyn Immuno Therapeutics, Inc.) since May 31, 2022 until May 04, 2023. He served as Chief Financial Officer and Secretary of Ra Medical Systems, Inc until May 25, 2022. He served as the Chief Financial Officer of Ra Medical Systems, Inc. since April 2018 until May 25, 2022 and served as its Secretary since August 2021 until May 25, 2022. He served as Secretary of Ra Medical Systems, Inc. since July 2018. Mr. Jackson had been an Interim Chief Executive Officer of Ra Medical Systems, Inc. since August 12, 2019 until March 29, 2020. From March 2014 to March 2016, he held senior financial positions, including Chief Financial Officer, at Celladon Corporation. Mr. Jackson served as the Chief Financial Officer of AltHeadx, Inc. since October 24, 2016 until April 2018. He served as the Chief Financial Officer of Celladon Corporation since May 2015, served as its Principal Accounting Officer since March 2015 and Corporate Controller since March 2014. From April 2013 to March 2014, he served as Corporate Controller at Sapphire Energy, Inc. From 2011 to 2013, Mr. Jackson served as Corporate Controller at REVA Medical, Inc. From 2006 to 2011, Mr. Jackson served as Assistant Corporate Controller at Quantum Fuel Systems Technologies Worldwide, Inc. He has finance experience. Mr. Jackson received a Bachelor of Science in Business (B.S.B.), Accounting in June 1992 from the University of Minnesota and a Master of Science in Business Administration (M.S.B. A), Finance in December 2006 from San Diego State University. Mr. Jackson is a Certified Public Accountant (inactive).
Positions
- Company NameCalidi Biotherapeutics, Inc.Stock CodeCLDIPositionCFO & Corporate SecretaryRelated SecuritiesColleagues
- EEEric E. PomaCEO & Director
- JAJames A. SchoeneckIndependent Chairman of the Board
- AFAntonio Fernandez SantidrianHead of Technical Operations & Chief Scientific Officer
- GTGuy Travis CliftonChief Medical Officer
- SLScott LeftwichIndependent Vice-Chairman of the Board
- ARAlan R. StewartIndependent Director
- DZDmitriy ZamarinMember of Scientific Advisory Board
